Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
作者信息
Poewe W
出版信息
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):430. doi: 10.1136/jnnp.72.4.430.
Abstract
摘要
相似文献
1
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.肉毒杆菌毒素A和Dysport的相对效价：一项关于颈部肌张力障碍的双盲、随机、交叉研究
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):430. doi: 10.1136/jnnp.72.4.430.
2
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.保妥适（Botox）与吉适（Dysport）的相对效力：一项关于颈部肌张力障碍的双盲、随机、交叉研究
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):459-62. doi: 10.1136/jnnp.72.4.459.
3
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.一项双盲、随机、平行组研究，旨在调查Dysport和保妥适在治疗颈部肌张力障碍方面的剂量等效性。
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):6-12. doi: 10.1136/jnnp.64.1.6.
4
Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.A型肉毒杆菌神经毒素不同制剂的药代动力学特性
Mov Disord. 2004 Mar;19 Suppl 8:S65-7. doi: 10.1002/mds.20012.
5
Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.用于治疗颈部肌张力障碍的肉毒杆菌神经毒素制剂的比较。
Clin Ther. 2007 Jul;29(7):1325-37. doi: 10.1016/j.clinthera.2007.07.020.
6
A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial.使用1:3和1:1.7剂量转换比的100 U/mL肉毒杆菌毒素和100 U/mL地宝毒素治疗颈部肌张力障碍的比较：一项双盲、随机、交叉试验。
Clin Neuropharmacol. 2015 Sep-Oct;38(5):170-6. doi: 10.1097/WNF.0000000000000101.
7
Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.从肉毒杆菌素（Dysport）转换为保妥适（BOTOX）治疗眼睑痉挛、颈部肌张力障碍和半面痉挛后，保妥适的安全性、有效性及疗效持续时间。
Curr Med Res Opin. 2005 Mar;21(3):433-8. doi: 10.1185/030079905X36396.
8
Comparing two botulinum toxin type A formulations using manufacturers' product summaries.使用制造商的产品概述比较两种A型肉毒杆菌毒素制剂。
J Clin Pharm Ther. 2007 Aug;32(4):387-402. doi: 10.1111/j.1365-2710.2007.00835.x.
9
Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.肉毒杆菌素A与保妥适以2.5:1单位比例用于治疗颈部肌张力障碍：一项双盲随机研究
Mov Disord. 2015 Feb;30(2):206-13. doi: 10.1002/mds.26085. Epub 2014 Dec 5.
10
Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.回复：初治的颈部肌张力障碍患者中B型肉毒毒素与A型肉毒毒素的对比：随机、双盲、非劣效性试验。
Mov Disord. 2009 May 15;24(7):1098-9; author reply 1100. doi: 10.1002/mds.22339.
引用本文的文献
1
Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia.转换为阿柏西普肉毒素A可延长颈部肌张力障碍的药效消退时间并提高疗效。
Mov Disord Clin Pract. 2023 Mar 1;10(5):756-763. doi: 10.1002/mdc3.13696. eCollection 2023 May.
2
A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.实用指南：优化 A 型肉毒毒素治疗脑卒中后痉挛的获益：国际专家组共识。
J Rehabil Med. 2021 Jan 1;53(1):jrm00134. doi: 10.2340/16501977-2753.
3
Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.临床实践中保妥适、吉适和乐提葆之间的换算比例。
Toxins (Basel). 2016 Mar 4;8(3):65. doi: 10.3390/toxins8030065.
4
Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.肉毒杆菌素A与保妥适以2.5:1单位比例用于治疗颈部肌张力障碍：一项双盲随机研究
Mov Disord. 2015 Feb;30(2):206-13. doi: 10.1002/mds.26085. Epub 2014 Dec 5.
5
Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study.两种A型肉毒杆菌毒素复合物（Dysport和保妥适）在志愿者中的生物活性：一项双盲、随机、剂量范围研究。
J Neurol. 2008 Dec;255(12):1932-9. doi: 10.1007/s00415-008-0031-7. Epub 2008 Oct 7.
Zotero 插件